资讯
Novartis will acquire Regulus Therapeutics for up to $1.7B, boosting its kidney drug pipeline with lead candidate farabursen.
3 天
Pharmaceutical Technology on MSNNovartis to strengthen renal disease portfolio with RegulusNovartis has agreed to acquire US-based Regulus Therapeutics and its oligonucleotide, farabursen, to bolster its renal ...
Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental ...
4 天
The Independent on MSNWoman baffled by painful periods had huge ovarian cyst filled with hair and teethWoman baffled by painful periods had huge ovarian cyst filled with hair and teeth - Valentina Milanova was told she might ...
A research team at the Technical University of Munich (TUM) has developed a method to predict early-stage kidney damage ...
Despite the diagnosis, Valentina continued to grapple with cysts, severe pain, bloating, and heavy bleeding. Her personal ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果